Foster Dykema Cabot & Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Sell |
60,923
-532
| -0.9% | -$237K | 1.91% | 19 |
|
|
2025
Q1 | $29.8M | Buy |
61,455
+591
| +1% | +$287K | 2.39% | 14 |
|
|
2024
Q4 | $24.5M | Buy |
60,864
+1,094
| +2% | +$441K | 1.91% | 19 |
|
|
2024
Q3 | $27.8M | Sell |
59,770
-205
| -0.3% | -$95.3K | 2.33% | 13 |
|
|
2024
Q2 | $28.1M | Buy |
59,975
+250
| +0.4% | +$117K | 2.51% | 11 |
|
|
2024
Q1 | $25M | Buy |
59,725
+2,299
| +4% | +$961K | 2.33% | 16 |
|
|
2023
Q4 | $23.4M | Buy |
+57,426
| New | +$23.4M | 2.48% | 10 |
|